| scholarly article | Q13442814 |
| P50 | author | Paul M Ness | Q107569672 |
| Seema Kacker | Q84843088 | ||
| P2093 | author name string | Kevin D Frick | |
| William J Savage | |||
| Aaron A R Tobian | |||
| Karen E King | |||
| R Sue Shirey | |||
| P2860 | cites work | Constructing a model: economic evaluations in transfusion medicine, Part 3 | Q86547324 |
| The costs of transfusion: economic evaluations in transfusion medicine, Part 1 | Q86547453 | ||
| Data and interpretation: economic evaluations in transfusion medicine, Part 4. | Q30612788 | ||
| An introduction to Markov modelling for economic evaluation | Q33581197 | ||
| Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial | Q34365555 | ||
| Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions | Q34564925 | ||
| Economic analyses of blood safety and transfusion medicine interventions: a systematic review | Q35739458 | ||
| Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management | Q36106307 | ||
| Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients | Q37136211 | ||
| Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease | Q37836673 | ||
| Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). | Q37844653 | ||
| Transfusion practices for patients with sickle cell disease at major academic medical centers participating in the Atlanta Sickle Cell Consortium. | Q39610661 | ||
| Recommendations of the Panel on Cost-effectiveness in Health and Medicine | Q41145868 | ||
| The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations | Q43048511 | ||
| Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions | Q43506933 | ||
| Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories | Q43811795 | ||
| Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood | Q44452119 | ||
| Establishing a framework: economic evaluations in transfusion medicine, part 2. | Q45006373 | ||
| Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood | Q45764858 | ||
| Antigen-matched red blood cell transfusions for patients with sickle cell disease at The Johns Hopkins Hospital | Q46149034 | ||
| The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. | Q46654188 | ||
| Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. | Q50646739 | ||
| Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. | Q50660151 | ||
| Transfusion management of patients with sickle cell disease: the continuing dilemma. | Q50718269 | ||
| Allosensitization in patients receiving multiple blood transfusions. | Q50747573 | ||
| Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease | Q68545154 | ||
| Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy | Q69738058 | ||
| A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group | Q72336907 | ||
| Transfusion protocol for patients with sickle hemoglobinopathies at Children's National Medical Center | Q84246660 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sickle-cell disease | Q185034 |
| P304 | page(s) | 2034-2044 | |
| P577 | publication date | 2014-02-27 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease | |
| P478 | volume | 54 |
| Q36068943 | 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. |
| Q41253789 | Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease |
| Q38616688 | CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model |
| Q37295865 | Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why? |
| Q47619489 | Direct costs of transfusion reactions - an expert judgement approach. |
| Q34792041 | Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models. |
| Q50437265 | Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion |
| Q38666286 | Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease. |
| Q52640370 | Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods. |
| Q52575393 | Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database. |
| Q42549198 | The future of red blood cell alloimmunization risk reduction |
Search more.